Literature DB >> 19815721

Virology. A new virus for old diseases?

John M Coffin1, Jonathan P Stoye.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19815721      PMCID： PMC2818280          DOI： 10.1126/science.1181349

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

Review 1.  Chronic fatigue syndrome.

Authors:  L D Devanur; J R Kerr
Journal:  J Clin Virol       Date:  2006-09-15       Impact factor: 3.168

2.  An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors.

Authors:  Beihua Dong; Sanggu Kim; Seunghee Hong; Jaydip Das Gupta; Krishnamurthy Malathi; Eric A Klein; Don Ganem; Joseph L Derisi; Samson A Chow; Robert H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-18       Impact factor: 11.205

3.  The low evolutionary rate of human T-cell lymphotropic virus type-1 confirmed by analysis of vertical transmission chains.

Authors:  S Van Dooren; O G Pybus; M Salemi; H-F Liu; P Goubau; C Remondegui; A Talarmin; E Gotuzzo; L C J Alcantara; B Galvão-Castro; A-M Vandamme
Journal:  Mol Biol Evol       Date:  2004-01-22       Impact factor: 16.240

4.  Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells.

Authors:  Emily C Knouf; Michael J Metzger; Patrick S Mitchell; Jason D Arroyo; John R Chevillet; Muneesh Tewari; A Dusty Miller
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

5.  Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer.

Authors:  Seunghee Hong; Eric A Klein; Jaydip Das Gupta; Kirsten Hanke; Christopher J Weight; Carvell Nguyen; Christina Gaughan; Kyeong-Ae Kim; Norbert Bannert; Frank Kirchhoff; Jan Munch; Robert H Silverman
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

6.  Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer.

Authors:  Sanggu Kim; Namshin Kim; Beihua Dong; David Boren; Serena A Lee; Jaydip Das Gupta; Christina Gaughan; Eric A Klein; Christopher Lee; Robert H Silverman; Samson A Chow
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

7.  XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors.

Authors:  Robert Schlaberg; Daniel J Choe; Kristy R Brown; Harshwardhan M Thaker; Ila R Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-08       Impact factor: 11.205

8.  Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.

Authors:  Anatoly Urisman; Ross J Molinaro; Nicole Fischer; Sarah J Plummer; Graham Casey; Eric A Klein; Krishnamurthy Malathi; Cristina Magi-Galluzzi; Raymond R Tubbs; Don Ganem; Robert H Silverman; Joseph L DeRisi
Journal:  PLoS Pathog       Date:  2006-03-31       Impact factor: 6.823

9.  A natural human retrovirus efficiently complements vectors based on murine leukemia virus.

Authors:  Beihua Dong; Robert H Silverman; Eugene S Kandel
Journal:  PLoS One       Date:  2008-09-04       Impact factor: 3.240
  9 in total
  16 in total

1.  Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected blood donors or individuals in Africa.

Authors:  Shixing Tang; Jiangqin Zhao; Ragupathy Viswanath; Phillipe N Nyambi; Andrew D Redd; Armeta Dastyar; Lisa A Spacek; Thomas C Quinn; Xue Wang; Owen Wood; Durga Gaddam; Krishnakumar Devadas; Indira K Hewlett
Journal:  Transfusion       Date:  2010-11-15       Impact factor: 3.157

2.  Virology: Fighting for a cause.

Authors:  Ewen Callaway
Journal:  Nature       Date:  2011-03-17       Impact factor: 49.962

3.  Xenotropic murine leukemia virus-related virus in chronic fatigue syndrome and prostate cancer.

Authors:  James N Baraniuk
Journal:  Curr Allergy Asthma Rep       Date:  2010-05       Impact factor: 4.806

4.  The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans.

Authors:  Graham Simmons; Simone A Glynn; Jerry A Holmberg; John M Coffin; Indira K Hewlett; Shyh-Ching Lo; Judy A Mikovits; William M Switzer; Jeffrey M Linnen; Michael P Busch
Journal:  Transfusion       Date:  2011-03-01       Impact factor: 3.157

5.  Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.

Authors:  Harriet C T Groom; Melvyn W Yap; Rui Pedro Galão; Stuart J D Neil; Kate N Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

Review 6.  Harnessing the potential of induced pluripotent stem cells for regenerative medicine.

Authors:  Sean M Wu; Konrad Hochedlinger
Journal:  Nat Cell Biol       Date:  2011-05       Impact factor: 28.824

Review 7.  The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome.

Authors:  Robert H Silverman; Carvell Nguyen; Christopher J Weight; Eric A Klein
Journal:  Nat Rev Urol       Date:  2010-06-01       Impact factor: 14.432

8.  Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors.

Authors:  Shyh-Ching Lo; Natalia Pripuzova; Bingjie Li; Anthony L Komaroff; Guo-Chiuan Hung; Richard Wang; Harvey J Alter
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

9.  Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome.

Authors:  Harriet C T Groom; Virginie C Boucherit; Kerry Makinson; Edward Randal; Sarah Baptista; Suzanne Hagan; John W Gow; Frank M Mattes; Judith Breuer; Jonathan R Kerr; Jonathan P Stoye; Kate N Bishop
Journal:  Retrovirology       Date:  2010-02-15       Impact factor: 4.602

10.  Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome.

Authors:  Ila R Singh; John E Gorzynski; Daria Drobysheva; Leda Bassit; Raymond F Schinazi
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.